Sikic Lab In the Division of Oncology

Sikic Lab Clinical Research

Current adult clinical protocols of modulation of drug resistance
and antisense gene therapy at Stanford University Medical Center.

For a complete listing of all cancer protocols and patient contact information,
please consult the Clinical and Translational Research Unit web page.

For information regarding active clinical trials in the United States,
please contact the National Cancer Institute at 1-800-4-CANCER (422-6237).


Protocol   Protocol Title
COR0006   A Phase I Trial of ZD6474 [Vandetanib] Combined with Capecitabine and Oxaliplatin (XELOX) and Bevacizumab for the First-Line Treatment of Metastatic Colorectal Cancer
VAR0021   A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of GDC-0973/XL518 Administered Orally Daily to Subjects with Solid Tumors – MEK4592g
VAR0031   A Phase I, Dose Escalation Study to Evaluate the Safety and Tolerability of AGE40826-2HCl
VAR0039   A Phase I, Dose Escalation Study of OMP-21M18 in Subjects with Solid Tumors
  A Phase 1b/2 Open Label, Dose Escalation Study of AMG 655 in Combination with AMG 479 in Subjects with Advanced, Refractory Solid Tumors
VAR0046   A Randomized Discontinuation Study of XL184 in Subjects with Advanced Solid Tumors

Related Publications


Stanford Medicine Resources:

Footer Links: